Real-world experience of OnabotulinumtoxinA treatment in female patients with chronic migraine: a qualitative study using in-depth interviews

Real-world experience of OnabotulinumtoxinA treatment in female patients with chronic migraine: a qualitative study using in-depth interviews

AbstractBackground Chronic migraine (CM) causes great disability and affects an individual’s quality of life. OnabotulinumtoxinA (OBT-A, Botox®) was the first prophylactic treatment specifically indicated for CM. The aim of this study was to describe the experiences of women with CM treated with OBT...

Full description

Bibliographic Details
Main Authors: Domingo Palacios-Ceña, Carlos Ordás-Bandera, Javier Casas-Limón, Jorge Pérez-Corrales, Javier Güeita-Rodríguez, José A. Arias-Navalón, María-Luz Cuadrado
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
(MeSH)
botulinum toxin type A
drug therapy
migraine disorders
women
qualitative research
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2255215

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2023.2255215

Similar Items